Author(s):
Sarika S. Lokhande, Raje V. N., More S. S., Pawar S. S.
Email(s):
sarikalokhande04@gmail.com
DOI:
10.52711/2231-5691.2023.00019 
Address:
Sarika S. Lokhande*, Raje V. N., More S. S., Pawar S. S.
Gourishankar College of Pharmacy (D. Pharm) Limb, Satara, Maharashtra.
*Corresponding Author
Published In:
Volume - 13,
Issue - 2,
Year - 2023
ABSTRACT:
In the last three decades role of pharmacist has changed dramatically. Presently, the pharmacists are becoming more patient oriented than product oriented. Patient counseling by pharmacist deals with providing information to the patients regarding the diseases, medications and lifestyle modifications. In diabetes, self management and patient adherence to the prescribed medication and lifestyle modifications is very essential and pharmacist can play an important role in counseling. A study was carried out to assess the influence of pharmacist provided patient counseling on patients' perception about quality of life in type 2 diabetes. 70 type-2 diabetes mellitus patients (48 males and 22 female) were enrolled and randomized into test and control groups. Mean capillary blood glucose levels were decreased in test group where as non-significant increase of capillary blood glucose levels was observed in the control group patients. Pharmacist provided patient counseling might be considered as an important element in implementing the disease management program.
Cite this article:
Sarika S. Lokhande, Raje V. N., More S. S., Pawar S. S. Role of Pharmacist in Prevention and Management of Diabetics. Asian Journal of Pharmaceutical Research. 2023; 13(2):95-8. doi: 10.52711/2231-5691.2023.00019
Cite(Electronic):
Sarika S. Lokhande, Raje V. N., More S. S., Pawar S. S. Role of Pharmacist in Prevention and Management of Diabetics. Asian Journal of Pharmaceutical Research. 2023; 13(2):95-8. doi: 10.52711/2231-5691.2023.00019 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2023-13-2-5
REFERENCES:
1. Heidi M, Harper A and Berger BA et al. Am J Pharm Educ 1992; 56: 252- 8
2. Popovich NG. Ambulatory patient care in Gennaro AR editor Remington: The science and practice of pharmacy vol 2. Mack publishing company, Pensylvania, 19th edition, 1995; 1695- 719
3. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005; 28 (4): 771-6
4. Setter SM, White JR, Campbell RK. Diabetes. In: Herfindal ET and Gourley DR, editors. Text book of therapeutics drug and disease management. Lippincots Williams and Wilkins, Baltimore. 7th edition; 377- 406.
5. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998; 13(11): 740-745.
6. Dooley M, Lyall H, Galbriath et al. SHPA standards of practice for clinical pharmacy. In: SHPA practice standards and definitions 1996. p. 2-11
7. New tool to enhance role of pharmacists in health care [news release]. Geneva, Switzerland: World Health Organization; November 23, 2006. http://www.who. int/mediacentre/news/new/ 2006/nw05/en/index.html. Accessed July 22, 2014
8. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 1998; 280: 1490- 96
9. American Diabetes Association: Diabetes mellitus and exercise. Diabetes Care (Indian Edition), 1998; 1: 65-9
10. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 2004; 328: 750e4.
11. Clifford RM, Davis WA, Batty KT, Davis TM. Diabetes Care 2005; 28(4): 771-6
12. Pinto SL, Bechtol RA, Partha G. Evaluation of outcomes of a medication therapy management program for patients with diabetes. J Am Pharm Assoc (2003). 2012: 52(4): 519-523
13. Diabetic control and complications (DCCT) trial research group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetic Control and Complications Trial. Kidney Int 1995; 47: 1703-20.
14. Pharmacy practice changing times, New roles, Chronicle pharmabiz, p.31, 13-12-2007
15. Shaping Pharmacy Profession. B. Suresh, Chronicle Pharmabiz, p.20, 13-12-2007
16. American Diabetes Association. Diabetes facts and figures. http://diabetes.org/diabetes-statistics.jsp. (Accessed on 27th January 2005)
17. Bredow T, Peterson S, Sandau K. Health-related quality of life. In: Peterson S, ed. Middle-Range Theories: Application to Nursing Research. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008: 273-289
18. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucosetoxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003; 52: 581–87.
19. Patient counseling in magic spell for better healthcare, scientific abstracts, p.512, 60th IPC, 2008.
20. Giberson S, Yoder S, Lee M. Improving patient and health system outcomes through advanced pharmacy practice. In: A Report to the US Surgeon General. US Public Health Service, Washington, DC, USA (2011).
21. Dooley M, Lyall H, Galbriath et al. SHPA standards of practice for clinical pharmacy. In: SHPA practice standards and definitions 1996. p. 2-11.
22. Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006; 28(2): 65-72.
23. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann. Pharmacother. 1996; 30(3): 2382–2343.
24. Whittemore R, D’EramoMelkus G, Grey M. Metabolic control, self-management and psychosocial adjustment in women with type 2 diabetes. J ClinNurs 2005; 14: 195–203.
25. Murawski M, Villa KR, Dole EJ et al. Advanced-practice pharmacists: practice characteristics and reimbursement of pharmacists certified for collaborative clinical practice in New Mexico and North Carolina. Am. J. Health Syst. Pharm. 2011; 68(24): 23412–23350.
26. Powell MF, Burkhart VD, Lamy PP. Diabetic patient compliance as a function of patient counseling. Drug Intell Clin Pharm 1979; 13(9): 506-11.
27. Kroon LA, Coleman LT, Koda-Kimble M. The management of Type 2 diabetes mellitus: a call to action for pharmacists. US Pharmacist May (Suppl. 1), 11–18 (1997)
28. Kagi, D. et al. (1997) Reduced incidence and delayed onset of diabetes in perforindeficientnonobese diabetic mice. J. Exp.Med. 186, 989–997
29. McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012; 32(5): 420-6.
30. Yang Q. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356–62.